
LCC in Mandarin: Virtual Tumor Board - EGFR NSCLC
LCC in Mandarin: Virtual Tumor Board - EGFR NSCLC by IASLC
16 Mar 202528min

Virtual Tumor Board: Targeting Residual Disease
Virtual Tumor Board: Targeting Residual Disease by IASLC
16 Mar 202549min

LCC in Korean: 2024 Lung Cancer Updates
LCC in Korean: 2024 Lung Cancer Updates by IASLC
16 Mar 202533min

Live from TTLC25: Lung Cancer and Brain Metastasis
Live from TTLC25: Lung Cancer and Brain Metastasis by IASLC
15 Mar 202519min

Lung Cancer Considered in Turkish: First-Line Therapies in EGFR Mutant NSCLC
Host: Ece Cali Daylan, Assistant Professor of Medicine, Division of Oncology at Washington University School of Medicine Guest: Saadettin Kilickap Guest: Ozden Altundag
15 Mar 202556min

Thymus Talk: Unraveling Thymoma and Thymic Carcinoma
This episode of Lung Cancer Considered takes an in-depth look at thymoma and thymic carcinomas, both challenging diseases to treat with evolving new therapeutics. Join host Dr. Narjust Florez and gues...
15 Mar 202545min

Lung Cancer Considered in Hungarian: Lung Cancer Treatment Updates
As part of IASLC's ongoing series of podcasts in world languages, Dr. Balazs Halmos moderates a discussion in Hungarian with Dr. Krisztina Bogos, Dr. Ferenc Rényi-Vámos and Dr. Zsolt Megyesfalvi. The ...
14 Mar 20251h 1min

LCC in Cantonese: WCLC24 Highlights
The 2024 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research and celebrate IASLC’s 50th anniversa...
9 Mar 202525min


















